Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis

British Journal of Pharmacology

Volumn 172, Issue 13, 2015, Pages 3383-3396

  Wan, Nian ^a,b   Liu, Xiaoxiong ^a,b   Zhang, Xiao Jing ^c   Zhao, Yichao ^d   Hu, Gangying ^a,b   Wan, Fengwei ^e   Zhang, Rui ^b   Zhu, Xueyong ^b   Xia, Hao ^a,b   Li, Hongliang ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c University of Macau   (Macao)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; TOLL INTERACTING PROTEIN; UNCLASSIFIED DRUG; SIGNAL PEPTIDE; TOLLIP PROTEIN, HUMAN; TOLLIP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOVASCULAR MORTALITY; CARDITIS; CELL ASSAY; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVATION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; HEART VENTRICLE; HYPOXIA; INFLAMMATION; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELLS, CULTURED; HEART VENTRICLES; HYPOXIA; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS, SPRAGUE-DAWLEY;

EID: 84937425943     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13130     Document Type: Article

References (54)

1. Alexander, SPH, Benson, HE, Faccenda, E, Pawson, AJ, Sharman, JL, Spedding, M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors. Br J Pharmacol 170: 1676-1705.
2. Alexander, SPH, Benson, HE, Faccenda, E, Pawson, AJ, Sharman, JL, Spedding, M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol 170: 1797-1867.
3. Amiel E, Acker JL, Collins RM, Berwin B, (2009). Uncoupling scavenger receptor A-mediated phagocytosis of bacteria from endotoxic shock resistance. Infect Immun 77: 4567-4573.
4. Baldi A, Abbate A, Bussani R, Patti G, Melfi R, Angelini A, et al. (2002). Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 34: 165-174.
5. Bulut Y, Faure E, Thomas L, Equils O, Arditi M, (2001). Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 167: 987-994.
6. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, et al. (2000). Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2: 346-351.
7. Byun EB, Mi S, Kim JH, Song DS, Lee BS, Park JN, et al. (2014). Epigallocatechin-3-gallate-mediated Tollip induction through the 67-kDa laminin receptor negatively regulating TLR4 signaling in endothelial cells. Immunobiology 219: 866-872.
8. Chandrashekhar Y, Sen S, Anway R, Shuros A, Anand I, (2004). Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 43: 295-301.
9. Chen K, Gao L, Liu Y, Zhang Y, Jiang DS, Wei X, et al. (2013). Vinexin-beta protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway. Basic Res Cardiol 108: 338.
10. Cochain C, Channon KM, Silvestre JS, (2013). Angiogenesis in the infarcted myocardium. Antioxid Redox Signal 18: 1100-1113.
11. Cravatt BF, Simon GM, Yates JR 3rd, (2007). The biological impact of mass-spectrometry-based proteomics. Nature 450: 991-1000.
12. Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, Kaslin E, et al. (2006). Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol Cell Biol 26: 735-742.
13. Dykxhoorn DM, Lieberman J, (2005). The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 56: 401-423.
14. Frangogiannis NG, (2012). Regulation of the inflammatory response in cardiac repair. Circ Res 110: 159-173.
15. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K, (2000). Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101: 660-667.
16. Hausenloy DJ, Yellon DM, (2004). New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61: 448-460.
17. Heineke J, Molkentin JD, (2006). Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600.
18. Heusch G, Libby P, Gersh B, Yellon D, Bohm M, Lopaschuk G, et al. (2014). Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383: 1933-1943.
19. Hu Y, Li T, Wang Y, Li J, Guo L, Wu M, et al. (2009). Tollip attenuated the hypertrophic response of cardiomyocytes induced by IL-1beta. Front Biosci (Landmark Ed) 14: 2747-2756.
20. Jiang DS, Bian ZY, Zhang Y, Zhang SM, Liu Y, Zhang R, et al. (2013). Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 61: 1193-1202.
21. Jiang DS, Li L, Huang L, Gong J, Xia H, Liu X, et al. (2014a). Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload. Hypertension 64: 77-86.
22. Jiang DS, Wei X, Zhang XF, Liu Y, Zhang Y, Chen K, et al. (2014b). IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat Commun 5: 3303.
23. Jiang DS, Zhang XF, Gao L, Zong J, Zhou H, Liu Y, et al. (2014c). Signal regulatory protein-alpha protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling. Hypertension 63: 96-104.
24. Jonassen AK, Sack MN, Mjos OD, Yellon DM, (2001). Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89: 1191-1198.
25. Jones BM, Kapadia SR, Smedira NG, Robich M, Tuzcu EM, Menon V, et al. (2014). Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J 35: 2060-2068.
26. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, Group NCRRGW (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
27. Kin H, Wang NP, Halkos ME, Kerendi F, Guyton RA, Zhao ZQ, (2006). Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/TNFalpha release after ischemia and reperfusion. J Surg Res 135: 170-178.
28. Lal H, Zhou J, Ahmad F, Zaka R, Vagnozzi RJ, Decaul M, et al. (2012). Glycogen synthase kinase-3alpha limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death. Circulation 125: 65-75.
29. Lee HJ, Chung KC, (2012). PINK1 positively regulates IL-1beta-mediated signaling through Tollip and IRAK1 modulation. J Neuroinflammation 9: 271.
30. Liu Y, Jiang XL, Jiang DS, Zhang Y, Zhang R, Chen Y, et al. (2014). Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice. Cardiovasc Res 101: 87-96.
31. Ma J, Wei M, Wang Q, Li J, Wang H, Liu W, et al. (2012). Deficiency of Capn4 gene inhibits nuclear factor-kappaB (NF-kappaB) protein signaling/inflammation and reduces remodeling after myocardial infarction. J Biol Chem 287: 27480-27489.
32. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
33. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
34. Pimentel-Nunes P, Goncalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque R Jr, et al. (2012). Decreased Toll-interacting protein and peroxisome proliferator-activated receptor gamma are associated with increased expression of Toll-like receptors in colon carcinogenesis. J Clin Pathol 65: 302-308.
35. Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, et al. (2013). Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury. Eur Heart J 34: 1834-1845.
36. Rafiq K, Kolpakov MA, Seqqat R, Guo J, Guo X, Qi Z, et al. (2014). c-Cbl inhibition improves cardiac function and survival in response to myocardial ischemia. Circulation 129: 2031-2043.
37. Riad A, Jager S, Sobirey M, Escher F, Yaulema-Riss A, Westermann D, et al. (2008). Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol 180: 6954-6961.
38. Schofield ZV, Woodruff TM, Halai R, Wu MC, Cooper MA, (2013). Neutrophils-a key component of ischemia-reperfusion injury. Shock 40: 463-470.
39. Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, et al. (2003). Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108: 2905-2910.
40. Suarez J, Wang H, Scott BT, Ling H, Makino A, Swanson E, et al. (2014). In vivo selective expression of thyroid hormone receptor alpha1 in endothelial cells attenuates myocardial injury in experimental myocardial infarction in mice. Am J Physiol Regul Integr Comp Physiol 307: R340-R346.
41. Sun Y, Yi W, Yuan Y, Lau WB, Yi D, Wang X, et al. (2013). C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation. Circulation 128 (11 Suppl. 1): S113-S120.
42. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, et al. (2008). Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 102: 257-264.
43. Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, et al. (2007). Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Diabetes 56: 363-372.
44. Wang L, Lu Y, Guan H, Jiang D, Guan Y, Zhang X, et al. (2013). Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction. J Neurochem 126: 400-414.
45. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, et al. (2003). A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111: 1497-1504.
46. Xiao J, Moon M, Yan L, Nian M, Zhang Y, Liu C, et al. (2012). Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction. Basic Res Cardiol 107: 239.
47. Xu N, Yu ZH, Yao QS, Wang ZQ, Qu HL, Sun Y, et al. (2013). PPAR-gamma and tollip are associated with toll-like receptors in colitis rats. J Immunoassay Immunochem 34: 219-231.
48. Xuan W, Liao Y, Chen B, Huang Q, Xu D, Liu Y, et al. (2011). Detrimental effect of fractalkine on myocardial ischaemia and heart failure. Cardiovasc Res 92: 385-393.
49. Yamashita K, Kajstura J, Discher DJ, Wasserlauf BJ, Bishopric NH, Anversa P, et al. (2001). Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 88: 609-614.
50. Yan L, Wei X, Tang QZ, Feng J, Zhang Y, Liu C, et al. (2011). Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3beta and TGF-beta1-Smad signalling. Cardiovasc Res 92: 85-94.
51. Zhang G, Ghosh S, (2002). Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem 277: 7059-7065.
52. Zhang Y, Kohler K, Xu J, Lu D, Braun T, Schlitt A, et al. (2011). Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture. J Mol Cell Cardiol 50: 471-478.
53. Zhang Y, Liu X, She ZG, Jiang DS, Wan N, Xia H, et al. (2014). Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury. Basic Res Cardiol 109: 434.
54. Zhao ZQ, Morris CD, Budde JM, Wang NP, Muraki S, Sun HY, et al. (2003). Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res 59: 132-142.